Klinične študije za BOPC v Tennessee
14 študij za BOPC išče udeležence na lokacijah v Tennessee.
Mesta v Tennessee
Uradno besedilo študije (angleško)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Chattanooga
- Research Site, Franklin
- Research Site, Tullahoma
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Chattanooga Research and Medicine- Site Number : 8400026, Chattanooga
- Premier Research Center, Llc- Site Number : 8400146, Hendersonville
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Meharry Medical College- Site Number : 8400133, Nashville
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Fort Sanders Regional Medical Center (StatCare), Knoxville
Vključevanje udeležencev
Starost 40–80 · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06035120A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Chattanooga
- Research Site, Franklin
Vključevanje udeležencevFaza 2
Starost 40 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Vanderbilt University Medical Center, Nashville
Vključevanje udeležencevFaza 2
Starost 40 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Knoxville
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Franklin
- Research Site, Johnson City
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Clinical Trials Center of Middle Tennessee, LLC, Franklin
- Premier Research Center, LLC, Hendersonville
Vključevanje udeležencevFaza 2/3
Starost 35–80 · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07363694Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
- The University of Tennessee Graduate School of Medicine, Knoxville
Vključevanje udeležencevFaza 4
Starost 40 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT07133880eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Knoxville
Vključevanje udeležencevFaza 3
Starost 40–75 · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT07177339Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Methodist LeBonheur Healthcare, Memphis
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT05181826Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Knoxville
Vključevanje udeležencevFaza 3
Starost 40–80 · Vsi spoli · Posodobljeno 9. apr. 2026 · NCT06961214Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- The Jackson Clinic, PA, Jackson
Vključevanje udeležencevOpazovalna študija
Starost 50 in več · Vsi spoli · Posodobljeno 5. avg. 2025 · NCT06122077Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.